✦ LIBER ✦

Cytomorphologic features of advanced lung adenocarcinomas tested for EGFR and KRAS mutations: A retrospective review of 50 cases

✍ Scribed by Jonathan D. Marotti; Mary C. Schwab; Nancy J. McNulty; James R. Rigas; Peter A. DeLong; Vincent A. Memoli; Gregory J. Tsongalis; Vijayalakshmi Padmanabhan

Book ID: 112072651
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 307 KB
Volume: 41
Category: Article
ISSN: 8755-1039
DOI: 10.1002/dc.21749

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mucinous Differentiation Correlates with

Mucinous Differentiation Correlates with Absence of EGFR Mutation and Presence of KRAS Mutation in Lung Adenocarcinomas with Bronchioloalveolar Features

✍ Finberg, Karin E.; Sequist, Lecia V.; Joshi, Victoria A.; Muzikansky, Alona; Mil 📂 Article 📅 2007 🏛 American Society for Investigative Pathology 🌐 English ⚖ 1011 KB

Reflex testing of resected stage I throu

Reflex testing of resected stage I through III lung adenocarcinomas for EGFR and KRAS mutation: Report on initial experience and clinical utility at a single center

✍ Sandra P. D’Angelo; Bernard Park; Christopher G. Azzoli; Mark G. Kris; Valerie R 📂 Article 📅 2011 🏛 CTSNet 🌐 English ⚖ 138 KB

Large-cell neuroendocrine carcinoma of l

Large-cell neuroendocrine carcinoma of lung with epidermal growth factor receptor (EGFR) gene mutation and co-expression of adenocarcinoma markers: a case report and review of the literature

✍ Sakai, Yasuhiro; Yamasaki, Takashi; Kusakabe, Yoshito; Kasai, Daisuke; Kotani, Y 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 430 KB

LUX-lung 3: A randomized, open-label, ph

LUX-lung 3: A randomized, open-label, phase III study of afatinib vs pemetrexed and cisplatin as first-line treatment for patients with advanced adenocarcinoma of the lung harboring EGFR-activating mutations

✍ Schuler, Martin; Yang, James Chih-Hsin; Yamamoto, Nobuyuki; O’Byrne, Ken; Hirsh, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 53 KB